Patent · US Active

Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation

US10010294B2 · kind B2 · utility

4Cited by

3References

20Claims

0Family size

Assignee

InCarda Therapeutics, Inc. · US

Inventors

Rangachari Narasimhan · Saratoga, US
Luiz Belardinelli · Palo Alto, US
Carlos Schuler · Cupertino, US

Key dates

Filing date	Feb 1, 2017
Grant date	Jul 3, 2018
Priority date	—
Expiry date	Feb 1, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2230/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods of treating cardiac arrhythmia with electronic monitoring in a timely manner. Also disclosed herein are systems for electronic monitoring of cardiac arrhythmia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.